Owens & Minor

103 articles with Owens & Minor

• Owens & Minor to Present at the BofA Securities 2020 Leveraged Finance Conference

  11/24/2020

  Owens & Minor, Inc. announced that the company will participate in the BofA Securities 2020 Leveraged Finance Conference on December 1, 2020.

• Owens & Minor Prepares for Flu Season with Increased Made-in-Americas Mask and N95 Respirator Capacity

  11/18/2020

  For the past 20 years, global healthcare manufacturer’s HALYARD-branded product line of masks and N95 respirators has ranked at the top of the facial protection market

• Owens & Minor to Present at the 29th Annual Credit Suisse Healthcare Conference

  11/5/2020

  Owens & Minor, Inc. announced that the company will participate in the 29th Annual Credit Suisse Healthcare Conference on November 12, 2020.

• Owens & Minor Reports 3rd Quarter Financial Results

  11/2/2020

  Owens & Minor, Inc. reported financial results for the third quarter of 2020, as summarized in the table below.

• Owens & Minor Will Report Third Quarter Financial Results on Monday, November 2, 2020

  10/15/2020

  Owens & Minor, Inc. plans to release financial results for the third quarter of 2020 on Monday, November 2, 2020, after trading ends on the New York Stock Exchange.

• Owens & Minor, Inc. Announces Offering of Common Stock

  9/29/2020

  Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced that it has commenced an underwritten public offering (the “Offering”) of $150,000,000 of shares of its common stock. The Company intends to grant the underwriters an option to purchase up to $22,500,000 of additional shares of common stock. The Company expects to use all or substantially all of the net proceeds from the Offering to repay debt and any rem

• Owens & Minor Announces Board Succession

  9/25/2020

  Owens & Minor, Inc. announced the implementation of a succession plan within its Board of Directors.

• Owens & Minor Updates Annual Earnings Guidance

  9/24/2020

  Owens & Minor, Inc. announced an increase in full year 2020 earnings guidance. The Company is revising its outlook for full-year adjusted net income from $1.00 to $1.20 per share to adjusted net income of $1.75 to $1.90 per share.

• Owens & Minor Reports 2nd Quarter 2020 Financial Results

  8/4/2020

  Owens & Minor, Inc. reported financial results for the second quarter of 2020, as summarized in the table below.

• Owens & Minor, Inc. Announces Final Results of Cash Tender Offers and Consent Solicitation for Senior Notes

  7/7/2020

  Owens & Minor, Inc. announced the final results and expiration of its previously announced offers to purchase for cash up to a maximum aggregate purchase price, excluding accrued interest, equal to $240 million of the Company’s 3.875% senior notes due 2021 and 4.375% senior notes due 2024 and related consent solicitation, upon the terms and conditions described in the Company’s Offer to Purchase and Consent Solicitation Statement dated June 5, 2020.

• Owens & Minor, Inc. Announces Early Results of Cash Tender Offers and Consent Solicitation for Senior Notes and Amendment to Terms of the Tender Offer for 2024 Notes

  6/19/2020

  Owens & Minor, Inc. announced the early results of its previously announced offers to purchase for cash up to a maximum aggregate purchase price, excluding accrued interest, equal to $240 million of the Company’s 3.875% senior notes due 2021 and 4.375% senior notes due 2024 and related Consent Solicitation, upon the terms and conditions described in the Company’s Offer to Purchase and Consent Solicitation Statement dated June 5, 2020.

• Owens & Minor Completes Sale of Movianto

  6/18/2020

  Owens & Minor, Inc. announced the completion of the sale of its European logistics business, Movianto, to EHDH Holding Group, one of Europe’s leading providers of healthcare logistics.

• Owens & Minor Announces Cash Tender Offers for Senior Notes

  6/5/2020

  Owens & Minor, Inc. (NYSE: OMI) (the “Company”) today announced that it has commenced offers to purchase for cash (collectively, the “Tender Offers” and each a “Tender Offer”) its outstanding senior notes listed in the table below for a maximum aggregate purchase price, excluding accrued interest, of up to $240,000,000 (the “Maximum Aggregate Purchase Price”) and, with respect to the 2021 Notes, a Consent Solicitation (

• Owens & Minor Announces Location Change for its 2020 Annual Meeting of Shareholders

  4/6/2020

  Annual Meeting to be webcast in virtual-only format

• Michael C. Riordan Elected to Owens & Minor Board of Directors

  12/9/2019

  Owens & Minor, Inc., a leading global healthcare solutions company, announced former Co-Chief Executive Officer and Director of Prisma Health, Michael C. Riordan, will join its Board of Directors.

• Owens & Minor Will Report Third Quarter 2019 Financial Results on Wednesday, November 6, 2019

  10/29/2019

  Management will host a conference call to discuss results at 8:30 a.m. EST on November 6th

• Owens & Minor Appoints Robert Henkel to Its Board of Directors

  10/1/2019

  Owens & Minor, Inc., a leading global healthcare solutions company, announced that healthcare industry veteran and former Ascension Health, Inc.

• Owens & Minor Opens Nominations for the 2019 Earl G. Reubel Awards

  9/23/2019

  Honoring Advocates for Diversity within the Healthcare Supply Chain

• Owens & Minor Declares 1st Quarter 2019 Dividend payable on March 29, 2019

  2/19/2019

  Owens & Minor, Inc. announced that its Board of Directors has approved a first quarter dividend payment of $0.0025 per share.

• Owens & Minor to Participate in 37th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019

  1/4/2019

  Owens & Minor, Inc. will participate in the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Thursday, January 10, 2019, at 9:30 a.m. Pacific Time